Showing 1 - 20 results of 25 for search 'Françoise Kraeber-Bodere', query time: 0.07s
Refine Results
-
1
Interest of FDG-PET in the Management of Mantle Cell Lymphoma by Clément Bailly, Clément Bailly, Thomas Carlier, Thomas Carlier, Cyrille Touzeau, Nicolas Arlicot, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Steven Le Gouill, Caroline Bodet-Milin, Caroline Bodet-Milin
Published 2019-04-01
Article -
2
Cell Tracking in Cancer Immunotherapy by Justine Perrin, Marisa Capitao, Marie Mougin-Degraef, Marie Mougin-Degraef, François Guérard, Alain Faivre-Chauvet, Alain Faivre-Chauvet, Latifa Rbah-Vidal, Joëlle Gaschet, Yannick Guilloux, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Jacques Barbet
Published 2020-02-01
Article -
3
[18F]-Fludarabine for Hematological Malignancies by Louisa Barré, Narinée Hovhannisyan, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Gandhi Damaj
Published 2019-04-01
Article -
4
Interest of Pet Imaging in Multiple Myeloma by Bastien Jamet, Clément Bailly, Clément Bailly, Thomas Carlier, Thomas Carlier, Cyrille Touzeau, Cyrille Touzeau, Cristina Nanni, Elena Zamagni, Louisa Barré, Anne-Victoire Michaud, Michel Chérel, Philippe Moreau, Philippe Moreau, Caroline Bodet-Milin, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré
Published 2019-04-01
Article -
5
Reply to E. Laffon et al. by Clément Bailly, Thomas Carlier, Françoise Kraeber-Bodéré, Steven Le Gouill, Caroline Bodet-Milin
Published 2020-01-01
Article -
6
Immuno-PET: Design options and clinical proof-of-concept by Alexandre Lugat, Clément Bailly, Clément Bailly, Michel Chérel, Michel Chérel, Caroline Rousseau, Caroline Rousseau, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2022-10-01
Article -
7
-
8
-
9
-
10
-
11
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches by Caroline Bodet-Milin, Caroline Bodet-Milin, Clément Bailly, Clément Bailly, Yann Touchefeu, Yann Touchefeu, Eric Frampas, Eric Frampas, Mickael Bourgeois, Mickael Bourgeois, Aurore Rauscher, Aurore Rauscher, Franck Lacoeuille, Delphine Drui, Nicolas Arlicot, David M. Goldenberg, David M. Goldenberg, Alain Faivre-Chauvet, Alain Faivre-Chauvet, Jacques Barbet, Caroline Rousseau, Caroline Rousseau, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré
Published 2019-06-01
Article -
12
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice by Aurélien Corroyer-Dulmont, Aurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, Jade Fantin, Kathleen Weyts, Katherine A. Vallis, Nadia Falzone, Nicola R. Sibson, Michel Chérel, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Alain Batalla, Stéphane Bardet, Myriam Bernaudin, Samuel Valable
Published 2021-08-01
Article -
13
Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma. by Clement Bailly, Rodolphe Leforestier, Loic Campion, Estelle Thebaud, Anne Moreau, Francoise Kraeber-Bodere, Thomas Carlier, Caroline Bodet-Milin
Published 2017-01-01
Article -
14
From a PMT-based to a SiPM-based PET system: a study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 450 by Thomas Carlier, Ludovic Ferrer, Maurizio Conti, Caroline Bodet-Milin, Caroline Rousseau, Yanic Bercier, Bernard Bendriem, Françoise Kraeber-Bodéré
Published 2020-09-01
Article -
15
-
16
Potential for Nuclear Medicine Therapy for Glioblastoma Treatment by Clément Bailly, Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2019-07-01
Article -
17
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial by Caroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, Gauthier Frecon, Olivier Tournilhac, Violaine Safar, Françoise Kraeber-Bodere, Steven Le Gouill, Elizabeth Macintyre, Clément Bailly
Published 2023-10-01
Article -
18
-
19
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET... by Bastien Jamet, Hatem Necib, Thomas Carlier, Eric Frampas, Juliette Bazin, Paul-Henri Desfontis, Aurélien Monnet, Caroline Bodet-Milin, Philippe Moreau, Cyrille Touzeau, Francoise Kraeber-Bodere
Published 2024-07-01
Article -
20
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin’s lymphoma by 18F-fluorodeoxyglucose positron emission tomography by Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Benoît Dupas, Franck Morschhauser, Thomas Gastinne, Steven Le Gouill, Loïc Campion, Jean-Luc Harousseau, William A. Wegener, David M. Goldenberg, Damien Huglo
Published 2008-03-01
Article